Cargando…
Ependyma: a new target for autoantibodies in neuromyelitis optica?
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease of the central nervous system characterized by the presence of autoantibodies (called NMO-IgG) targeting aquaporin-4. Aquaporin-4 is expressed at the perivascular foot processes of astrocytes, in the glia limitans, but also at the epe...
Autores principales: | Bigotte, Maxime, Gimenez, Marie, Gavoille, Antoine, Deligiannopoulou, Adamantia, El Hajj, Aseel, Croze, Severine, Goumaidi, Abdelghafar, Malleret, Gael, Salin, Paul, Giraudon, Pascale, Ruiz, Anne, Marignier, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897195/ https://www.ncbi.nlm.nih.gov/pubmed/36751497 http://dx.doi.org/10.1093/braincomms/fcac307 |
Ejemplares similares
-
Pathogenic role of autoantibodies at the ependyma in autoimmune disorders of the central nervous system
por: Bigotte, Maxime, et al.
Publicado: (2023) -
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
por: Marignier, R., et al.
Publicado: (2016) -
The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab
por: Nicolas, Philippe, et al.
Publicado: (2019) -
Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2020) -
Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)